BNP Paribas Arbitrage SNC Has $594,000 Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)

BNP Paribas Arbitrage SNC trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 59.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,626 shares of the medical instruments supplier’s stock after selling 6,897 shares during the quarter. BNP Paribas […]

Related Keywords

United States ,America ,Asia Pacific ,John Bradley Schmieder ,Securities Exchange Commission ,Invesco Ltd ,Nasdaq ,Vanguard Group Inc ,Biopharmaceutical Development ,Blackrock Inc ,Mesa Laboratories Company Profile ,Morgan Stanley ,Calibration Solutions ,Mesa Laboratories Inc ,Mesa Laboratories ,Free Report ,State Street Corp ,Street Corp ,Get Free Report ,Director John Bradley Schmieder ,Exchange Commission ,North America ,Clinical Genomics ,Disinfection Control ,Mesa Laboratories Daily ,Nasdaq Mlab ,Mlab ,Medical ,59064r10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,